Welcome Guest
Home > Supportive Cancer Therapy > Volume 4 |  Issue 4

Table of Contents

Volume 4 |  Issue 4

Publication Date: September 2007
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Editorial
Page Number of this Article in the Print Version
178-179		 Hitting Our Stride
Jeffrey Crawford
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Reviews
Page Number of this Article in the Print Version
182-187		 Urinary N-Telopeptide Is a Rapid Predictor of Response to and Palliative Benefit from Bisphosphonate Therapy in Patients with Metastatic Breast Cancer
Christine Simmons, Reuben J. Broom, David E. C. Cole, George Dranitsaris, Mark Clemons
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
188-197		 The Effect of Palifermin on Chemotherapy- and Radiation Therapy—Induced Mucositis: A Review of the Current Literature
Anne W. Beaven, Thomas C. Shea
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
198-202		 Sunshine and Rash: Testing the Role of Sunscreen to Prevent Epidermal Growth Factor Receptor Inhibitor—Induced Rash
Aminah Jatoi
  • Abstract
  • No Access
  • Add to Cart
Original Contributions
Page Number of this Article in the Print Version
203-210		 Rapid and Sustained Influence of Intravenous Zoledronic Acid on Course of Pain and Analgesics Consumption in Patients with Cancer with Bone Metastases: A Multicenter Open-Label Study Over 1 Year
Albrecht Kretzschmar, Thomas Wiegel, Salah-Eddin Al-Batran, Hans Fokke Hinrichs, Manfred Kindler, Thomas Steck, Hans Jochen Illiger, Volker Heinemann, Katja Schmidt, Ulrike Haus, Alexandra Kirner, Gerhard Ehninger
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
211-218		 Palmar-Plantar Erythrodysesthesia in Patients Receiving Capecitabine and Intratumor Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase: Is There a Pharmacologic Explanation?
Muhammad Wasif Saif, Vinni Juneja, Glenda Black, Jennifer Thronton, Martin R. Johnson, Robert B. Diasio
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
219-224		 Phase II Evaluation of Desipramine for the Treatment of Hot Flashes
Debra L. Barton, Charles L. Loprinzi, Pamela Atherton, Jane Raymond, Tait Shanafelt, Stephanie Hines, Fran Palmieri, Teresa Rummans, Alex A. Adjei, Jeff Sloan
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
225-232		 An Extended Dosing Regimen of Epoetin Alfa 60,000 Units Every 2 Weeks in Anemic Patients with Cancer Receiving Chemotherapy
Stephanie A. Gregory, John Xie, Tomek Szczudlo, Denise Williams, Richard C. Woodman, Francois E. Wilhelm
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
233-240		 Symptom Burden for Patients with Metastatic Colorectal Cancer Treated with First-Line FOLFOX or FOLFIRI with and Without Bevacizumab in the Community Setting
Barry V. Fortner, Lee S. Schwartzberg, Edward J. Stepanski, Arthur C. Houts
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
241-246		 Topiramate in the Treatment of Neuropathic Pain in Patients with Cancer
Edmond A. Bendaly, Carol A. Jordan, Sandra S. Staehler, Daniel A. Rushing
  • Abstract
  • No Access
  • Add to Cart
Current Trials
Page Number of this Article in the Print Version
247-250		 A Phase II/III Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Ginger (Zingiber officinale) for Nausea Caused by Chemotherapy for Cancer: A Currently Accruing URCC CCOP Cancer Control Study
Jane T. Hickok, Joseph A. Roscoe, Gary R. Morrow, Julie L. Ryan
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
251-253		 Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: Rationale for an Ongoing Clinical Trial
Lisa Kottschade, Charles Loprinzi, Ravi Rao
  • Abstract
  • No Access
  • Add to Cart